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Ischemic heart disease is one of the most common causes of death worldwide. Mitochondrial
dysfunction, excessive reactive oxygen species (ROS) generation, and calcium (Ca2þ) overload are three
key factors leading to myocardial death during ischemia-reperfusion (I/R) injury. Inhibition of TRPM4, a
Ca2þ-activated nonselective cation channel, protects the rat heart from I/R injury, but the specific
mechanism underlying this effect is unclear. In this study, we investigated the mechanism of car-
dioprotection against I/R injury via TRPM4 using hydrogen peroxide (H2O2), a major contributor to
oxidative stress, as an I/R injury model. We knocked out the TRPM4 gene in the rat cardiomyocyte cell
line H9c2 using CRISPR/Cas9. Upon H2O2 treatment, intracellular Ca2þ level and ROS production
increased in wild type (WT) cells but not in TRPM4 knockout (TRPM4KO) cells. With this treatment, two
indicators of mitochondrial function, mitochondrial membrane potential (DJm) and intracellular ATP
levels, decreased in WT but not in TRPM4KO cells. Taken together, these findings suggest that blockade of
the TRPM4 channel might protect the myocardium from oxidative stress by maintaining the mito-
chondrial membrane potential and intracellular ATP levels, possibly through preventing aberrant in-
creases in intracellular Ca2þ and ROS.
© 2021 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ischemic heart disease (IHD) is one of the most common causes
of death worldwide. Currently, IHD causes more than 30% of the
annual deaths of people over 35 years of age [1]. Thus, IHD is a
major health problem in imminent need of solutions. The pathol-
ogy underlying IHD involves atherosclerosis of the coronary artery
caused by plaques. Plaque accumulation narrows the artery,
resulting in reduced or disrupted blood flow that alters oxygen
metabolism in the heart, leading to a heart attack [2]. At present,
percutaneous coronary intervention and coronary artery bypass
graft are commonly used to resolve coronary artery blockage. Over
the past 3 decades, these procedures have decreased IHD mortality
dramatically by decreasing the infarct area [3]. However, mounting
clinical evidence demonstrates severe adverse events following
reperfusion, including myocardial stunning, microvascular. Wang), takah-k2@okayama-
r Inc. This is an open access articleobstruction, fatal arrhythmias, acute cardiac failure, and sudden
death. Collectively, these outcomes are known as ‘reperfusion
injury.’ Thus, ischemia-reperfusion (I/R) is recognized as a double-
edged sword that can rescue the ischemic myocardium but also
carries a risk of clinical complications that decrease patient survival
[4e6].
The mechanism underlying myocardial ischemia-reperfusion (I/
R) injury is complex and not fully understood. A decrease in
myocardial oxygen caused by an ischemic event leads to mito-
chondrial dysfunction that results in attenuation of the mitochon-
drial membrane potential (DJm). This mitochondrial membrane
depolarization leads to adenosine triphosphate (ATP) depletion and
calcium (Ca2þ) overload, resulting in cell death [7,8]. Meanwhile,
oxidative stress response is an important feature of myocardial I/R
injury, which is manifested to generate reactive oxygen species
(ROS). Although ischemic injury is initially resolved with the return
of oxygen (O2), a burst of ROS occurs during reperfusion that causes
oxidative damage to lipids, proteins, and DNA. Increased ROS also
causes further loss of mitochondrial function [9e11]. Thus, mito-
chondrial dysfunction, Ca2þ overload, and ROS overproduction are
three key factors involved in the development of myocardial I/Runder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
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The transient receptor potential melastatin member 4 (TRPM4),
a nonselective monovalent cation channel, is impermeable to Ca2þ
but regulated by the intracellular Ca2þ concentration [12]. The
TRPM4 channel opens in response to increased intracellular Ca2þ,
causing sodium (Naþ) influx that leads to membrane depolariza-
tion. These changes cause gradual swelling of cells that eventually
leads to cell death [13]. ATP also mediates the activity of TRPM4
channels, which open in response to low intracellular ATP con-
centrations [13,14]. A study by Gerzanich et al. reports that low
intracellular ATP led to the death of COS-7 cells expressing TRPM4
[15]. Taken together, these observations indicate that ATP modu-
lates TRPM4 activity.
Our previous study showed that inhibiting TRPM4 with 9-
phenanthrol rescued rat myocardial I/R damage, as evidenced by
decreases in LDH level, infarct size, and ventricular fibrillation
[16,17]. The specificmechanismwhereby TRPM4 inhibition protects
against myocardial I/R injury is unknown. Here, we hypothesize
that blockade of TRPM4 channels in cardiomyocytes during I/R af-
fects 1) DJm, 2) mitochondrial ATP production, 3) intracellular
Ca2þ level, and 4) intracellular ROS production. To test this hy-
pothesis, we performed CRISPR knockout of the TRPM4 protein in
rat H9c2 cardiomyocytes and treated the cells with exogenous
oxidative stress stimulus, hydrogen peroxide (H2O2), to mimic I/R
injury.2. Materials and methods
2.1. Cell culture
The H9c2 rat cardiomyocyte line was purchased from American
Type Cell Culture (Manassas, VA, USA). The cells were cultured in
Dulbecco's Modified Eagle's Medium (DMEM, Thermo Fisher Sci-
entific) supplemented with 10% fetal bovine serum (FBS, Sigma-
Aldrich, St. Louis, MO, USA) in a humidified incubator (5% CO2,
20% O2) at 37 C. Wild type (WT) and TRPM4 knockout (TRPM4KO)
cells were seeded into 96-well plates (104 cells/well) for detecting
level of cell viability, DJm, ATP, and Ca2þ. For the detection of ROS
production, the cells were seeded into 48-well plates (2 104 cells/
well), grown to 80% confluence.2.2. Oxidative stress stimulation with H2O2
To mimic I/R injury, cells were treated with 500 mM H2O2 in
DMEM supplemented with 10% FBS to induce cell damage (100 ml/
well). Untreated control cells were incubated in fresh DMEM with
10% FBS at 37 C for 4 h (100 ml/well). Cell viability, DJm, ATP
concentration, intracellular Ca2þ concentration, and ROS produc-
tion were compared between WT and TRPM4KO cells.2.3. MTT assay of cell viability
The viability of WT and TRPM4KO cells was quantified using the
MTT Cell Proliferation Assay Kit (Cayman Chemical Company, Ann
Arbor, MI, USA). After 4 h of H2O2 treatment as described, the
medium containing H2O2 was replaced with fresh DMEM (100 ml/
well), and 10 ml MTT reagent (5 mg/ml) was added to each well.
Samples were incubated in the dark at 37 C for 3 h. The medium
containing MTT reagent was removed, and the formazan crystals in
each well were dissolved in 200 ml of dimethyl sulfoxide (Nacalai
Tesque, Japan). The absorbance of the solution in each well was
measured with a microplate reader at a wavelength of 570 nm.1912.4. Measurement of mitochondrial membrane potential (DJm)
The DJm was determined using the JC-1 Mitochondrial Mem-
brane Potential Assay Kit (Cayman Chemical Company, Ann Arbor,
MI, USA). After 4 h of H2O2 exposure, the medium was replaced
with JC-1 staining solution (100 ml/well). The cells were incubated
in the dark at 37 C for 20 min. The solution was replaced with
100 ml fresh DMEM, and JC-1 fluorescence was detected by fluo-
rescence microscopy. Briefly, the JC-1 dye is a lipophilic, cationic
dye (naturally exhibiting green fluorescence) that is extensively
used for monitoring mitochondrial health in apoptosis studies. This
dye enters the mitochondria, where it accumulates and forms
reversible complexes called J aggregates. Healthy cells with a
normal DJm are detected as red fluorescent J-aggregates (excita-
tion/emission ¼ 540/570 nm). In contrast, J-monomers, which
fluoresce green (excitation/emission ¼ 485/535 nm), are formed in
apoptotic or damaged cells due to insufficient intake of the JC-1
dye. The ratio of J-aggregates to J-monomers (red/green) repre-
sents the DJm, with mitochondrial depolarization indicated by a
lower ratio [18]. The fluorescence intensity was measured using
Image-J.
2.5. Measurement of ATP level
Intracellular ATP was measured using the Luminescent ATP
Detection Assay Kit (Abcam, USA). After 4 h of H2O2 application, the
medium in each well was substituted with 50 ml of detergent so-
lution and shaken for 10 min in a bioshaker at 300 rpm. Recon-
stituted substrate solution (50 ml) was added to each well and
shaken on a bioshaker at 300 rpm for 10 min. The samples were
kept at room temperature in the dark for 10 min, and the lumi-
nescence was visualized and the intensity was measured using a
Fujifilm LAS-3000 Imager (FUJIFILM, Japan).
2.6. Measurement of intracellular Ca2þ
Intracellular Ca2þ was measured using Fura-2-AM dye (Life
technologies, USA). The cells were loaded with 5 mM Fura-2 reagent
(100 ml/well) after H2O2 treatment, then incubated at 37 C for 1.5 h,
and washed twice with standard external solution (140 mM NaCl,
5 mM KCl, 2 mM CaCl2$2H2O, 10 mMD-glucose, and 10 mM HEPES,
pH 7.4), to remove extracellular dye and maintained in standard
external solution (100 ml/well). Fura-2 fluorescence was measured
at wavelengths of 340 nm and 380 nm, and the intensity of fluo-
rescence was calculated (AquaCosmos 2.6 analysis system).
2.7. Reactive oxygen species production assay
The level of intracellular ROS production in WT and TRPM4KO
cells was determined using CM-H2DCFDA (Invitrogen, Carlsbad, CA,
USA), a chloromethyl derivative of H2DCFDA. After 4 h of treatment
with 500 mMH2O2, all cells were incubated with CM-H2DCFDA (final
concentration,1 mM) in the dark at 37 C for 20min and rinsed twice
with phosphate-buffered saline (PBS, Nissui Pharmaceutical, Japan).
ROS production was assessed by fluorescence intensity using a
fluorescence microscope (excitation/emission ¼ 485/535 nm). The
fluorescence intensity was measured using Image-J.
2.8. Statistical analysis
All data are presented as the mean ± standard error of the mean
and were analyzed using Prism software (version 8.0, Graphpad
Software, USA). Comparisons between two groups were conducted
using Student's t-test. Results were considered statistically signifi-
cant for p < 0.05.
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diomyocytes, DNA sequencing, and Western blot analysis for con-
firming knockout are described in [31].
3. Results
3.1. H2O2-induced cell death was ameliorated in TRPM4
KO H9c2
cells
The viability of H9c2 exposed to 4 h of 500 mM-H2O2 was
monitored by MTT assay. As shown in Fig. 1A, the WT cells shrunk
dramatically and were fewer in number after H2O2 treatment. In
TRPM4KO cells, no changes were observed in cell morphology or
number after H2O2 treatment. The viability of TRPM4KO cells was
nearly triple than that of WT cells (0.84 ± 0.04 vs. 0.29 ± 0.06,
normalized to untreated cells; p < 0.0001) after H2O2 treatment
(Fig. 1B).
3.2. H2O2 -induced mitochondrial dysfunction was attenuated in
TRPM4KO H9c2 cells
The DJm in H9c2 treated with 500 mM H2O2 for 4 h was eval-
uated using JC-1 staining with fluorescence microscopy. JC-1
staining showed an aggregated pattern of energized mitochon-
dria (red fluorescence) and a monomeric pattern for depolarized
mitochondria (green fluorescence). As shown in Fig. 2A, compared
to untreated cells, WT cells showed remarkably lower red fluores-
cence and higher green fluorescence after H2O2 treatment, indi-
cating significant loss of DJm. In sharp contrast, TRPM4KO cells
showed higher red fluorescence and lower green fluorescence,
indicating that TRPM4KO cells resisted the H2O2-induced DJm
depletion. The difference in the normalized fluorescence ratio, an
indicator for the DJm, between WT and TRPM4KO was statistically
significant (0.28 ± 0.06 vs. 0.72 ± 0.05, respectively; p < 0.001)
(Fig. 2B).
Meanwhile, another indicator of mitochondrial function, intra-
cellular ATP, was measured as well. After H2O2 treatment, the
intracellular ATP concentration in TRPM4KO cells was significantly
higher than that in WT cells (0.79 ± 0.06 vs. 0.41 ± 0.02,Fig. 1. H2O2-induced cell death was ameliorated in TRPM4KO H9c2 cells. (A) The morph
microscopy. Scale bar: 100 mm. (B) Cell viability as determined by MTT assay. After H2O2 e
viability was normalized by dividing the absorbance of cells treated with H2O2 by that of
represent SEM. ****p < 0.0001 vs WT.
192respectively; p < 0.001) (Fig. 2C). These results suggest that mito-
chondrial function can be protected from oxidative stress by
inhibiting TRPM4 channel.
3.3. H2O2-induced intracellular Ca
2þ overload was suppressed in
TRPM4KO cells
To investigate the involvement of TRPM4 in the regulation of
intracellular Ca2þ in response to increased oxidative stress, we
compared the intracellular Ca2þ levels in response to H2O2 expo-
sure between WT and TRPM4KO cells. Although a large increase in
intracellular Ca2þ was observed in theWTcells in response to H2O2
treatment, this response was significantly inhibited in TRPM4KO
cells (Fig. 3A). In response to H2O2 treatment, the increase in Ca2þ
was 0.19 ± 0.06 inWT but0.03 ± 0.03 in TRPM4KO cells, indicating
no increase in intracellular Ca2þ in TRPM4KO group after H2O2
exposure (p < 0.01) (Fig. 3B). These results suggest that the intra-
cellular Ca2þ overload under oxidative stress involves the TRPM4
channel function.
3.4. H2O2-induced increase in ROS production was lower in
TRPM4KO cells
To investigate the involvement of the TRPM4 channel in ROS
production in response to exogenous ROS exposure, we compared
intracellular ROS levels in response to H2O2 exposure between WT
and TRPM4KO cells. In WT cells, we observed more intense fluo-
rescence in H2O2 -treated than in untreated cells (4.30 ± 0.14 times
higher) (Fig. 4A). In TRPM4KO cells, no significant difference in
fluorescence was observed between H2O2-treated and untreated
cells (2.20 ± 0.63 times higher; p < 0.05 vs. WT) (Fig. 4B). These
results suggest that the TRPM4 channel is involved in the oxidative
stress induced ROS overproduction.
4. Discussion
Previous studies have shown that inhibition of TRPM4 by 9-
phenanthrol ameliorates cardiac injury in the rat [16,17].
Although these studies clearly indicate involvement of the TRPM4ology of WT and TRPM4KO cells treated with 500 mM-H2O2 for 4 h was observed via
xposure, cell viability was significantly higher in TRPM4KO cells than in WT cells. Cell
untreated cells. Chart represents average of five independent experiments. Error bars
Fig. 2. H2O2-induced mitochondrial dysfunction was attenuated in TRPM4KO H9c2 cells. (A) Change in DJm in WT and TRPM4KO cells after treatment with 500 mM H2O2 for 4 h
was observed via fluorescence microscopy. JC-1 staining showed an aggregated pattern of energized mitochondria (red fluorescence) and a monomeric pattern for depolarized
mitochondria (green fluorescence). Scale bar: 200 mm. (B) The DJmwas substantially preserved after H2O2 exposure in TRPM4KO cells. DJmvalues were normalized by dividing the
fluorescence intensity of H2O2-treated cells by that of untreated cells. (C) The level of ATP was effectively preserved in TRPM4KO cells after H2O2 exposure. The ATP level was
normalized by dividing the luminescent intensity of H2O2-treated cells by that of untreated cells. Chart represents average of five independent experiments. Error bars represent
SEM. ***p < 0.001 vs WT. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
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nism of such involvement is unclear. In this study, we investigated
the mechanism of cardioprotection against I/R injury via TRPM4
using H2O2 as an I/R injury model in rat cardiomyocytes with and
without TRPM4 knockout. Upon H2O2 treatment, intracellular cal-
cium level and ROS production increased in WT but not TRPM4
knockout cells; in addition, the DJm and intracellular ATP levels,
indicators of mitochondrial function, both decreased in WT but not
TRPM4 knockout cells. Taken together, these findings suggest that
blockade of the TRPM4 channel protects the myocardium from
oxidative stress damage by maintaining mitochondrial function,
possibly by preventing aberrant increases in intracellular calcium
and ROS.193In the mechanism underlying myocardial I/R injury, mitochon-
drial dysfunction and a significant accumulation of Ca2þ are triggers
of cell apoptosis and damage. Impaired mitochondria usually
exhibit membrane depolarization and ATP depletion [7]. According
to Nilius et al. the TRPM4 channel is activated by an increase in
intracellular Ca2þ and a decrease in ATP, leading to intracellular Naþ
overload, ending in cell death [19]. H2O2 induces sustained TRPM4
activity, resulting in deleterious processes that lead to cell death
[20]. Thus, ischemia-reperfusion may activate TRPM4, further
exacerbating I/R injury by promoting sodium influx. Thus, inhibit-
ing the TRPM4 channel may prove useful for preventing a variety of
I/R injuries. The following discussion addresses the protective effect
of TRPM4 inhibition against myocardial I/R injury with respect to
Fig. 3. H2O2-induced accumulation of intracellular Ca2þ was prevented in TRPM4KO H9c2 cells. (A) Changes in Ca2þ concentration in WT and TRPM4KO cells treatment with
500 mM H2O2 for 4 h was determined by fluorescence microscopy. Scale bar: 200 mm. (B) TRPM4 knockout in H9c2 cardiomyocytes prevented the intracellular Ca2þ overload under
oxidative stress induced by H2O2. Ca2þ levels were normalized by dividing the difference in fluorescence intensity between H2O2-treated and untreated cells by the fluorescence
intensity of untreated cells. Chart represents average of seven independent experiments. Error bars represent SEM. **p < 0.01 vs WT.
Fig. 4. H2O2-induced ROS production was lower in TRPM4KO cells. (A) Comparison of ROS production (green fluorescence) between WT and TRPM4KO cells treated with
500 mM H2O2 for 4 h using fluorescence microscopy. Scale bar: 100 mm. (B) The accumulation of ROS in response to H2O2 exposure was suppressed effectively in TRPM4KO cells. ROS
levels were normalized by dividing the difference in fluorescence intensity of cells treated with and without H2O2 by that of untreated cells. *p < 0.05. (For interpretation of the
references to colour in this figure legend, the reader is referred to the Web version of this article.)
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Consistent with our hypothesis, under H2O2 exposure, a com-
mon chemical model of I/R injury, the mitochondria of WT H9c2
cardiomyocytes with intact TRPM4 activity showed a sharp decline
in DJm. Conversely, the DJm was preserved in TRPM4 knockout194cardiomyocytes treated with H2O2 (Fig. 2AeB). As the DJm is a
known indicator of mitochondrial activity [21], this observation
suggests that the decrease in mitochondrial membrane depolari-
zation resulting from TRPM4 inhibition reflects the protection of
mitochondrial function.
Impaired mitochondrial function decreases ATP production.
After H2O2 treatment, the ATP level in TRPM4KO cells was almost
twice than that of WT cells (Fig. 2C), indicating that TRPM4
C. Wang, J. Chen, M. Wang et al. Biochemical and Biophysical Research Communications 566 (2021) 190e196inhibition preserves intracellular ATP production in the presence of
H2O2. The health of cardiomyocytes depends on an adequate en-
ergy supply, which decreases during the process of I/R injury
[11,22]. Thus, maintenance of energy is crucial to prevent myocar-
dial I/R damage. Previous studies have shown that a sufficient ATP
supply can suppress cell death related to TRPM4 activity [13,23].
Thus, the maintenance of normal intracellular ATP level by func-
tional mitochondria decreases the risk of cell death from TRPM4
activation under oxidative stress. In summary, inhibiting the
expression or activity of TRPM4 may be a useful option to rescue
ROS-induced mitochondrial dysfunction and prevent H9c2 car-
diomyocyte deaths.
4.2. Calcium overload
TRPM4 channel activity induced by elevated intracellular Ca2þ
has been proposed to play a role in cell apoptosis and necrosis [13].
Intracellular Ca2þ overload is a major mediator of cell damage or
death during myocardial I/R injury. The sodium-calcium exchanger
(NCX) is a well-characterized ion transport protein expressed on
the plasma membranes of all types of animal cells. Under normal
physiological conditions, the NCX of cardiomyocytes maintains low
intracellular Ca2þ concentrations by removing Ca2þ from the cell,
thereby effectively regulating cardiac conduction and contractile
function [24,25]. During ischemia-reperfusion, NCX can work in
reverse, pumping Ca2þ into the cell, resulting in a rise in intracel-
lular Ca2þ. This pathological process is attributed to an I/R-induced
increase in Hþ concentration that activates the Naþ-Hþ exchanger
to promote Hþ extrusion, leading to an increase in intracellular Naþ.
The reverse-mode of NCX is activated by this elevated intracellular
Naþ, causing intracellular Ca2þ overload [10,25,26]. Thus, the NCX is
an important mediator of intracellular Ca2þ overload in myocardial
I/R injury.
Because TRPM4 is impermeable to Ca2þ, cell death resulting
from TRPM4 activation is usually attributed to a rise in intracellular
Naþ. An alternative hypothesis is that sustained intracellular Naþ
overload caused by TRPM4 activity causes NCX towork in reverse to
cause Ca2þ accumulation in the cell that eventually leads to cell
death [13]. Salcedo et al. reported that high level of intracellular
Ca2þ in neurons during cerebral ischemia-reperfusion resulted in
constitutive activity of TRPM4, resulting in neuron depolarization
and eventual death [27]. Thus, accumulation of intracellular Ca2þ
may be a common and important feature of I/R injury and TRPM4
activation. We observed that after H2O2 treatment, intracellular
Ca2þ level increased approximately 20% in WT cells but decreased
in TRPM4KO cells (Fig. 3). This observation shows that the intra-
cellular Ca2þ overload induced by oxidative stress was completely
prevented by knockout of TRPM4 in H9c2 cardiomyocytes.
The initial ATP loss in myocardial I/R injury is caused by ATP
consumption during anaerobic metabolism. This alteration hinders
the activity of ATPases (Naþ/Kþ ATPase, sarcoplasmic reticulum/
endoplasmic reticulum Ca2þ ATPase) and also disrupts the trans-
port of Ca2þ to the endoplasmic reticulum. As a consequence, Ca2þ
accumulates in the cell, leading to Ca2þ overload. The mitochon-
drial permeability transition pore opens in response to the rise in
intracellular Ca2þ, accelerating mitochondrial depolarization and
causing a marked decrease in intracellular ATP [7,10]. Thus, a
decrease in TRPM4 activity suppresses intracellular Ca2þ accumu-
lation and may help to rescue dysfunctional mitochondria, pre-
venting cell death under oxidative stress.
4.3. ROS overproduction
The results of this study and others suggest that the TRPM4
channel plays a role in the cellular injury mediated by ROS. Becerra195et al. observed that TRPM4 channel inhibition suppressed endo-
thelial cell apoptosis caused by elevated intracellular ROS-induced
by lipopolysaccharide treatment [28]. Salcedo et al. reported that
elevated ROS production during I/R injury activated TRPM4, leading
to neuronal death [27]. Furthermore, Ding et al. reported that
exogenous ROS can significantly upregulate the expression of
TRPM4, leading to extensive endothelial cell apoptosis; the TRPM4-
inhibitor 9-phenanthrol suppressed this apoptosis [29]. In the
present study, our results show that the H2O2-induced increase in
ROS production was dramatically suppressed in TRPM4KO car-
diomyocytes (Fig. 4). Together, these findings suggest that sup-
pression of TRPM4 expression may protect cardiomyocytes from
the overproduction of ROS that causes cell death during I/R injury.
The link between the TRPM4 channel activity andmitochondrial
dysfunction may be explained by ROS overproduction. We
observed here that H2O2, a type of ROS, induced an increase in
intracellular ROS. This result may result from ‘ROS-induced ROS
release (RIRR)’ in mitochondria. In RIRR, overproduced ROS can
damage mitochondria [30]. Interestingly, we observed that mito-
chondrial dysfunction, as evidenced by abnormal mitochondrial
membrane depolarization and a marked decrease in ATP produc-
tion, was resolved in TRPM4KO cardiomyocytes. Therefore, the
mechanism underlying cardioprotection by TRPM4 inhibition may
involve the inhibition of RIRR that occurs in mitochondria.
Our findings indicate that inhibition of the TRPM4 channel
rescues mitochondrial dysfunction during H2O2 exposure by pre-
serving the mitochondrial membrane potential and ATP levels. In
addition, decreased expression of TRPM4 protects cardiomyocytes
against oxidative stress by limiting accumulation of intracellular
Ca2þ and ROS. Inhibition of TRPM4 may be a valuable and novel
strategy for suppressing myocardial ischemia-reperfusion injury.
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